PAVmed grants 110,000 shares to general counsel

Gordon Michael Adam reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 04/03/2026 - 04:45 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Gordon Michael Adam reported acquisition or exercise transactions in this Form 4 filing.

PAVmed Inc. granted its General Counsel, Michael Adam Gordon, 110,000 shares of restricted common stock as equity compensation. The shares were granted at no cash cost and bring his direct holdings to 115,000 shares. The award vests on May 20, 2029 and is subject to forfeiture if he does not complete the required service period, making this a long-term retention incentive rather than an open-market purchase.

Insider Trade Summary

Grant/Award: 110,000 shares

Grant/Award 1 txn

Insider Gordon Michael Adam

Role General Counsel

Type	Security	Shares	Price	Value
Grant/Award	Common stock	110,000	$0.00	$0.00

Holdings After Transaction: Common stock — 115,000 shares (Direct)

Holdings Before and After: Common stock, 5,000 to 115,000 shares (Direct)

Footnotes (1)

1. F1. Represents restricted stock granted to the reporting person under the Issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed.

Key Figures

Restricted stock grant: 110,000 shares Grant price: $0.00 per share Post-grant holdings: 115,000 shares +1 more

4 metrics

Restricted stock grant 110,000 shares Award of common stock to General Counsel

Grant price $0.00 per share Equity compensation, not open-market purchase

Post-grant holdings 115,000 shares Direct common stock ownership after transaction

Vesting date May 20, 2029 Single vesting date for restricted stock

Key Terms

restricted stock, long-term incentive equity plan, vesting, forfeiture

4 terms

restricted stock financial

"Represents restricted stock granted to the reporting person under the Issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

long-term incentive equity plan financial

"under the Issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan"

vesting financial

"with a single vesting date of May 20, 2029"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

forfeiture financial

"Such restricted stock is subject to forfeiture if the requisite service period is not completed"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did PAVmed (PAVM) report for its General Counsel?

PAVmed reported that its General Counsel, Michael Adam Gordon, received 110,000 shares of restricted common stock as an equity award. The grant is compensation, not an open-market purchase, and was priced at zero cash cost under the company’s long-term incentive equity plan.

How many PAVmed (PAVM) shares does the General Counsel hold after this grant?

After the restricted stock grant, PAVmed’s General Counsel directly holds 115,000 shares of common stock. This implies his prior direct position was 5,000 shares, and the award significantly increases his equity-based compensation and long-term alignment with shareholders.

When does the new restricted stock award at PAVmed (PAVM) vest?

The 110,000-share restricted stock award is scheduled to vest on May 20, 2029. Vesting occurs only if the required service period is fully completed, meaning the General Counsel must remain in qualifying service through that date to receive the shares outright.

Is the PAVmed (PAVM) General Counsel’s stock grant an open-market purchase?

No, the transaction is a grant of restricted stock, not an open-market purchase. The Form 4 shows an acquisition under the company’s long-term incentive equity plan at a stated price of $0.00 per share, reflecting compensation rather than a cash investment in the market.

What conditions could cause forfeiture of the PAVmed (PAVM) restricted shares?

The restricted shares are subject to forfeiture if the requisite service period is not completed. If the General Counsel leaves or fails to meet service requirements before May 20, 2029, some or all of the 110,000 granted shares may be lost under the plan’s terms.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gordon Michael Adam

(Last) (First) (Middle)

360 MADISON AVENUE, 25TH FLOOR

(Street)

NEW YORK NEW YORK 10017

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PAVmed Inc. [ PAVM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	General Counsel

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock	04/02/2026		A		110,000(1)	A	$0	115,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock granted to the reporting person under the Issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed.

	/s/ Michael A. Gordon	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)